Through suppressing the IL-6/STAT3 pathway and drug transporter ABCC10, let-7, and let-7g/i could restore the sensitivity to DDP and oxaliplatin and promote apoptosis of esophageal cancer cells (Sugimura et al., 2012; Wu et al., 2016). Here, STAT3 is linked to esophageal cancer.